I

Summary of Day Synthesis

A hawkish FOMC reversal: green into the decision, sold red into the close

▶

A hawkish FOMC reversal: green into the decision, sold red into the close

Stocks gave back intraday gains to finish broadly lower: the S&P 500 (SPY) fell 1.25% to 740.96, the Nasdaq 100 (QQQ) slid 1.01% to 722.51, and the Russell 2000 (IWM) dropped 0.75% to 289.88.
Large caps led the slide — SPY fell more than the small-cap IWM — consistent with the index's biggest names being sold rather than defended into the bell.
Precious metals offered no shelter: gold (GLD) dropped 2.27% and silver (SLV) tumbled 4.39%, while WTI crude (USO) eased 1.07% — risk-off with no obvious safe haven.
The tape's edges were all speculation: IceCure Medical (ICCM) tripled to $6.40 (+200.47%) and Eshallgo (EHGO) jumped 118.94%, while INLIF (INLF) collapsed 88.55% to $0.44 and Veraxa Biotech (VRXA) shed 38.05%.
Net read: not a crash but a re-rating to a more hawkish Fed, with the day defined by the late fade rather than the morning strength.

Context & Source Read

·LLM The first FOMC under the new chair read as a genuine hawkish surprise — a policy-bias shift taken at face value and sold into the close.

·LLM Megacaps led the drop rather than defending it, leaving few places to hide inside the index.

·LLM Gold trading heavy alongside equities fits a real-yield backup, not a flight to safety.

▶ Raw Source Quotes · all mentions

LLM

Not a crash — a re-rating.

The reversal — green into the decision, red into the bell — is the whole story.

II

Price Performance Data

S&P 500 (SPY) −1.25% · Nasdaq 100 (QQQ) −1.01% · Russell 2000 (IWM) −0.75% · Gold (GLD) −2.27% · WTI Crude (USO) −1.07% · Silver (SLV) −4.39%

▶

S&P 500 (SPY)740.96−1.25%Nasdaq 100 (QQQ)722.51−1.01%Russell 2000 (IWM)289.88−0.75%Gold (GLD)388.60−2.27%WTI Crude (USO)114.23−1.07%Silver (SLV)60.61−4.39%

VIX and the U.S. Dollar Index (DXY) are not shown: the current market-data plan does not include index quotes. Restoring them needs a Massive indices package.

Relative Strength · current RS + 1D / 1W / 1M moves + distance below 52-week high

Component	Current RS	% 1D	% 1W	% 1M	% off 52W H
Broad Indices
SPYS&P 500	50	−1.25	+2.14	+0.31	−2.56
QQQNasdaq 100	81	−1.01	+4.15	+2.36	−3.49
IWMRussell 2000	69	−0.75	+2.78	+5.04	−2.7
DIADow 30	48	−0.99	+3.21	+3.88	−1.5
Market Segments
IWFLarge-cap Growth	48	−1.42	+1.6	−2.01	−5.84
IWDLarge-cap Value	51	−1.06	+2.19	+3.31	−2.09
MTUMMomentum	100	+0.68	+7.66	+11.54	−2.33
SPHBHigh Beta	100	−0.67	+8	+11.26	−3.17
SPLVLow Volatility	8	−1.6	−0.78	0	−5.69
IWOSmall-cap Growth	78	−0.36	+4.06	+6.28	−2.36
IWNSmall-cap Value	60	−1.16	+1.31	+3.69	−3.02
Equal-Weight Sectors
RSPS&P 500 Equal Weight	37	−1.5	+1.19	+3.05	−2.48
RSPTTechnology (EW)	100	−0.98	+4.57	+8.28	−7.42
RSPFFinancials (EW)	42	−0.94	+2.06	+2.69	−4.36
RSPNIndustrials (EW)	30	−1.26	+3.3	+3.96	−3.35
RSPHHealth Care (EW)	21	−1.87	−1.54	+3.22	−6.21
RSPDConsumer Discretionary (EW)	19	−2.37	+1.77	+6.43	−8.35
RSPSConsumer Staples (EW)	9	−2.51	−2.74	−0.53	−10.52
RSPUUtilities (EW)	0	−1.35	+0.76	+1.92	−6.28
RSPMMaterials (EW)	29	−1.13	+4.89	+3.58	−4.27
RSPGEnergy (EW)	0	−1.14	−6.01	−9.69	−13.35
RSPRReal Estate (EW)	30	−2.25	−3.01	+1.46	−4.09
RSPCCommunication Svcs (EW)	0	−2.44	−2.6	−5.58	−13.76
Sector SPDRs
XLKTechnology	100	−0.34	+5.19	+6.56	−6.51
XLFFinancials	44	−0.55	+3.48	+4.46	−4.36
XLIIndustrials	39	−0.14	+5.86	+5.18	−1.5
XLVHealth Care	18	−1.46	−1.4	+3.42	−6.15
XLYConsumer Discretionary	25	−2.51	+1.76	−0.71	−7.62
XLPConsumer Staples	14	−2.23	−2.12	−2.58	−7.17
XLUUtilities	0	−1.33	+1.05	+1.18	−6.99
XLBMaterials	34	−1.33	+4.88	+3.58	−3.92
XLEEnergy	0	−1.25	−6.15	−9.76	−13.85
XLREReal Estate	25	−2.51	−2.27	+0.5	−3.68
XLCCommunication Svcs	0	−2.78	−1.63	−6.65	−9.31

Current RS is BCM's own relative-strength reading, not a third-party rating: each row's trailing 3-month return minus the S&P 500's, mapped to a 0 to 100 scale where 50 is in line with the market, above 50 is leading, and below 50 is lagging.

III

Review of Key Themes Synthesis

4 themes: Risk-off into the close · Hawkish Fed re-rating · No haven in metals or crude · Single-name dispersion beneath a heavy tape

▶

Risk-off into the close

All three major equity gauges finished lower, with the S&P 500 (SPY) down 1.25% to 740.96, the Nasdaq 100 (QQQ) off 1.01% to 722.51, and the Russell 2000 (IWM) down 0.75% to 289.88. The decline was broad and large-cap-led rather than a rotation between sectors or sizes.

▶

Context & Source Read

·LLM The day's narrative framed it as stocks giving back an intraday gain to close red across the board — green into the decision, red into the bell.

Hawkish Fed re-rating

The selloff was framed as a hawkish FOMC surprise under the new chair, with equities erasing early gains to finish lower across the board. The move read as an index-wide re-rating of the rate path rather than a growth scare confined to one sector.

▶

Context & Source Read

·LLM Per the day's narrative, the megacaps led the drop rather than defending it, and the front end of the curve repriced near-term hike risk — a cleaner read on the hawkish surprise than the equity move itself.

No haven in metals or crude

Gold (GLD) fell 2.27% to 388.6 and silver (SLV) dropped 4.39% to 60.61 — the day's worst-performing instrument — offering no shelter on a down day for equities. WTI crude (USO) also slipped 1.07% to 114.23, leaving few places to hide across asset classes.

▶

Context & Source Read

·LLM The narrative read gold as trading heavy under the hawkish guidance as real yields backed up.

Single-name dispersion beneath a heavy tape

Beneath the index weakness, speculative single names ran hot in both directions: IceCure Medical (ICCM) surged 200.47% to $6.40 and Eshallgo (EHGO) jumped 118.94% to $2.89, while INLIF (INLF) collapsed 88.55% to $0.44 and Veraxa Biotech (VRXA) fell 38.05%. The wide dispersion shows risk appetite is alive in pockets even as the broad market sold off.

▶

Context & Source Read

IV

LLM Unfiltered Summary Off-Leash

A broad, source-free read on the day — the unconstrained second opinion. ~3 min.

▶

≈ 3 min read · no curated sources · Off-leash AI read — Opus 4.8, web-sourced; not investment advice.

The new Fed got its introduction, and the market did not enjoy it. Stocks were higher for most of the session and gave it all back after 2pm: the S&P 500 closed down ~1.2% at 7,420.10, the Nasdaq off ~1.3% at 26,021.66, the Dow down 507 points (~1.0%) at 51,492.55. The reversal — green into the decision, red into the bell — is the whole story. This was the first FOMC under Kevin Warsh, and it was, per the tape, the worst "Fed day" for the S&P under a new chair since 1994.

What actually mattered

The rate hold at 3.50–3.75% (12–0) was never the event; the projections were. The 2026 dot median jumped to 3.8% from 3.4% in March — nine of eighteen officials now pencil in at least one hike this year, eight hold, one cuts. The committee also marked up 2026 inflation hard: headline PCE to 3.6% and core to 3.3%, both from 2.7%. In one update the Fed went from "we'll probably ease" to "we might hike," and the statement was stripped of any cut bias. Warsh withheld his own dot and said the Fed has dropped forward guidance — less hand-holding, more headline risk.

The front end did the talking. The 2-year yield jumped ~16 bps to ~4.22% while the 10-year added ~7 bps to ~4.50%. That flattening is the bond market repricing near-term hike risk, not a growth scare — a cleaner read on the hawkish surprise than the equity move.
Megacaps led the drop, not defended it. Microsoft, Meta, Alphabet and Amazon all closed red. When the generals are the ones being sold on a rate scare, there's no obvious place to hide inside the index.
Gold offered no shelter, trading heavy under the hawkish guidance as real yields backed up. (Intraday it was near ~$4,330; I can't pin the exact close.)

How I'd frame it

The bearish read is straightforward: the policy bias has genuinely turned, the inflation forecast moved the wrong way, and an expensive market just lost its rate-cut crutch — sold by its biggest names, with the front end screaming. The more constructive case is that a single hawkish hold doesn't break a bull market; the data, not the dots, decides whether that hike actually arrives, and a Fed willing to lean against inflation early can be the thing that prevents a worse problem later.

What I'd watch from here: whether the 2-year holds its new level or fades (a fade says the market doesn't believe the hike), whether megacap selling was a one-day repricing or the start of multiple compression, and whether tomorrow's tape stabilizes or extends. Net for Wednesday: a genuine hawkish surprise, taken at face value and sold into the close. Not a crash — a re-rating. The new chair told the market it's on its own, and the market flinched.

V

Top Movers List Data

Gainers led by ICCM +200.47% · EHGO +118.94% · SDOT +98.15%. Worst: INLF −88.55% · VRXA −38.05%.

▶

Gainers

ICCMIceCure Medical Ltd.+200.47%$6.40

EHGOEshallgo Inc.+118.94%$2.89

SDOTSadot Group Inc.+98.15%$17.18

QUREuniQure N.V.+78.44%$48.16

ELTXElicio Therapeutics, Inc.+70.65%$4.71

ALOTAstroNova, Inc.+69.86%$28.35

HQWWWHorizon Quantum Holdings Ltd. Warrant+63.36%$12.17

LNAILunai Bioworks Inc.+40.6%$4

Losers

INLFINLIF LIMITED−88.55%$0.44

VRXAVeraxa Biotech AG−38.05%$5.86

FLZHFlash Sports & Media Holdings, Inc.−32.21%$2.61

SLBTSL Science Holding Limited−28.23%$6.38

LILAKLiberty Latin America Ltd.−25.87%$5.25

LILALiberty Latin America Ltd.−25.16%$5.30

SPROSpero Therapeutics, Inc.−23.83%$2.11

UBXGU-BX Technology Ltd.−23.4%$7.43

VI

RIP Analysis Awaiting Source

Awaiting StockTwits RIP (from Jared).

▶

AWAITING SOURCE · StockTwits RIP (from Jared)

VII

Vital Analysis Compile · V.K.

V.K. cut — JBL · KMX · MU.

▶

The close
The SPX fell 91 points/121bp to 7420 (intra-day range 7532-7402), while the equal-weight version of the index did worse (it dropped ~150bp). The Dow ended off 506 points/97bp, the Nasdaq sank 354 points/134bp, and the R2K tumbled 21 points/72bp.
Fed drove the slump
It was a quiet session until 2pmET, when the Fed decision kicked off a significant slump in both equities and part of the Treasury curve. The issue wasn't just the hawkish shift in policy bias but the dramatic increase in uncertainty over how the central bank plans to comport itself going forward — Warsh was adamant about not providing forward guidance, with a series of task forces weighing seismic changes through year-end. The market is now pricing in 40bp worth of Fed hikes in the second half of the year.
Rates, dollar, commodities
Treasuries saw violent swings, with Fed-sensitive 2-year yields surging 16bp while 10-year yields only ticked up 5bp and 30-year yields dipped 1.5bp. The DXY spiked 100bp and Brent was about flat. Gold sank 205bp, silver tumbled 410bp, and bitcoin dropped 250bp (to ~$64.13K).
Internals
Leadership came from chips/components, capital goods, and banks/brokers, while software/services, internet, transports, travel/leisure, staples, and housing underperformed; autos/auto retailers, exchanges, and cable/telecom also lagged.
JBLKMXEarnings standouts
JBL reported modest FQ3 EPS upside ($3.16 vs. the Street $3.10), with the beat driven by higher sales ($8.75B vs. $8.63B) and better margins (op. margins 5.76% vs. 5.67%); F26 guidance is moving higher and management feels "very good" about the F27 setup. KMX reported solid FQ1 EPS upside but slumped despite the beat.
MUAhead
With Iran, SpaceX, and the Fed out of the way, the calendar is pretty sparse between now and the start of CQ2 earnings, although one major off-cycle report remains: Micron on Wed 6/24 after the close.

VIII

DTR Recap Awaiting Source

Awaiting DTR Discord recap (from Jared).

▶

AWAITING SOURCE · DTR Discord recap (from Jared)

IX

Ariel W/L and Recap Awaiting Source

Awaiting Ariel W&L / REL recap (from Jared).

▶

AWAITING SOURCE · Ariel W&L / REL recap (from Jared)

X

Day 2 List with Analysis Synthesis

6 fresh names added for tomorrow — ICCM, SDOT, QURE, INLF, VRXA, LILAK — each explained across every source.

▶

Grade	Company	Catalyst		Change
—	ICCM IceCure Medical Ltd. Healthcare	A triple-digit single-session spike on what reads as a binary news event — regulatory, partnership, or data — for this small-cap medical device name. A +200% move on a risk-off day, when the S&P fell 1.25% and megacaps led the index lower, is pure idiosyncratic flow, not market beta. Gaps this size in micro-caps often round-trip; the tell tomorrow is whether volume holds the new level or unwinds.	▶	+200.47% $6.40
Context & Source Read
—	SDOT Sadot Group Inc. Consumer	Stock nearly doubled intraday, a move consistent with a corporate action, contract, or low-float squeeze rather than fundamentals. A near-100% gain against a tape that gave back all its gains after the FOMC dots showed a 2026 median jumping to 3.8% signals this is detached from the macro story. Worth flagging for follow-through, but treat as speculative until a durable catalyst is confirmed.	▶	+98.15% $17.18
Context & Source Read
—	QURE uniQure N.V. Healthcare	A large gap higher in a clinical-stage gene therapy name, the kind of move that typically follows trial data, an FDA interaction, or partnership news. Unlike the micro-cap pops, QURE at $48 with a +78% move is a real-dollar event that fund books will notice. That it ran hard on a day the front end repriced hike risk and biotech's rate sensitivity is high makes the strength notable — single-name news beat the macro headwind.	▶	+78.44% $48.16
Context & Source Read
—	INLF INLIF LIMITED Healthcare	A near-total collapse to $0.44, the signature of a failed binary event, dilution/offering, or post-IPO/SPAC unwind. An 88% one-day loss is a capital-destruction event, not a dip. Sub-$1 pricing raises listing-compliance risk; this is a cautionary flag rather than a dip-buy, and the move is firm-specific given the index was only down ~1%.	▶	−88.55% $0.44
Context & Source Read
—	VRXA Veraxa Biotech AG Healthcare	A sharp one-third haircut, consistent with disappointing data, a financing overhang, or a lockup-related supply event in a small-cap biotech. A 38% drawdown stands out as the kind of single-name biotech break that compounds an already rate-sensitive sector's bad day. Watch whether selling stabilizes or extends — capitulation versus a slower bleed changes the setup.	▶	−38.05% $5.86
Context & Source Read
—	LILAK Liberty Latin America Ltd. Communication Services	A 26% decline in a leveraged telecom name, with its sister share class LILA down a near-identical 25.16% — a both-classes move that points to a company-level event, not a single-line glitch. Highly leveraged operators are acutely exposed to the day's story: a 2-year yield up ~16 bps and a Fed bias that flipped from easing to a possible hike raise the cost of refinancing. The parallel drop across LILAK and LILA makes this the most macro-coherent loser on the board.	▶	−25.87% $5.25
Context & Source Read

XI

Earnings Plays Placeholder

Coming soon — after-hours earnings reactions with beat/miss and the AH move. Shell only in V1.

▶

Earnings Plays · coming soon